From The Standard, by Kudzai Chimhangwa

The success of tests into the effectiveness of anti-HIV gels to be used by women before engaging in sex has presented Zimbabwe with another chance of further reducing the rapid transmission of the virus. According to various presentations made at a feedback workshop organised by the United Nations Population Fund (UNFPA) and the National Aids Council (NAC) on Friday, the research on the gels has brought a lot of hope. One of the gels is based on the anti-retroviral (ARV) drug Tenofovir and recent research carried out in South Africa showed that it reduces transmission of Aids to women if used before sex.